This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
ICE Stock Trades Below 50-Day SMA: What Should You Do Now?
by Tanuka De
Intercontinental Exchange is poised for growth on the strength of its compelling portfolio and expansive risk-management services, strategic buyouts and a solid balance sheet.
Cboe Global Stock Slips Below 50-Day SMA: What Should You Do Now?
by Zacks Equity Research
CBOE's strong market position, global reach, proprietary product strength and solid capital position poise it for growth.
Zacks Industry Outlook Intercontinental Exchange, CME Group, Nasdaq, Cboe Global Markets and MarketAxess
by Zacks Equity Research
Intercontinental Exchange, CME Group, Nasdaq, Cboe Global Markets and MarketAxess have been highlighted in this Industry Outlook article.
5 Stocks to Watch From the Prospering Securities and Exchanges Industry
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, NDAQ, CBOE and MKTX. However, compliance with regulations remains a challenge.
Why Is MarketAxess (MKTX) Down 11.1% Since Last Earnings Report?
by Zacks Equity Research
MarketAxess (MKTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ICE Stock Outperforms Industry YTD: Time to Add it for Better Returns?
by Tanuka De
Investors who already hold Intercontinental Exchange stock should retain it, while new investors can wait for a better entry point given its growth prospects.
Cboe Global Stock Lags Industry in 3 Months: Should You Buy?
by Tanuka De
CBOE's strategy of expanding product line across asset classes, broadening geographic reach and diversifying the business mix reflects operational expertise.
Nasdaq Stock Surges 43% YTD: What Should Be Investors' Approach Now?
by Tanuka De
NDAQ is set to grow on an increasing on-trading revenue base, impressive organic growth and investment in proprietary data supported by a solid capital position.
Cboe Global Q3 Earnings Top Estimates on Record Derivatives Volume
by Zacks Equity Research
CBOE's third-quarter results reflect record volumes across the company's derivatives platform.
Intercontinental's Q3 Earnings Match Estimates, Segment Results Solid
by Zacks Equity Research
ICE's third-quarter results reflect the strength of a balanced and diversified business as well as the benefits of the strategic investments it has made.
Nasdaq Tops Q3 Earnings Estimates, Tweaks Expense Guidance
by Zacks Equity Research
NDAQ's third-quarter results reflect broad-based growth across three divisions and another quarter of double-digit Solutions growth.
Nasdaq (NDAQ) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Nasdaq (NDAQ) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Nasdaq (NDAQ) Tops Q3 Earnings Estimates
by Zacks Equity Research
Nasdaq (NDAQ) delivered earnings and revenue surprises of 7.25% and 1.80%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
CME Group Q3 Earnings and Revenues Beat Estimates on Higher Volumes
by Zacks Equity Research
CME's third-quarter results reflect record trading volumes. Average daily volume increased in its six asset classes, with average daily volume up 20% in commodities and 28% in financial markets.
Can CME Group Retain its Beat Streak This Earnings Season?
by Zacks Equity Research
A diverse product portfolio, increased volatility and a strong market position are likely to have aided CME's performance in the third quarter.
Nasdaq Gears Up to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
NDAQ's Q3 performance is likely to have been driven by organic revenue growth, new sales, higher segmental revenues and contributions from acquisitions.
Stay Ahead of the Game With Nasdaq (NDAQ) Q3 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Nasdaq (NDAQ), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
Nasdaq (NDAQ) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ICE Trading at Premium to Industry at 24.93X: What Should You Do?
by Tanuka De
Investors who already hold Intercontinental Exchange stock should retain it and new investors can wait for a better entry point given its growth prospects.
Nasdaq Trading Near 52-Week High: How Should You Play the Stock?
by Zacks Equity Research
NDAQ is poised to gain from impressive organic growth, strategic buyouts to capitalize on growing market opportunities and effective capital deployment.
CBOE Stock Trading at Discount to Industry at 22.50X: Should You Buy?
by Tanuka De
A diversified business mix with recurring revenues, accelerated growth banking on recurring non-transaction revenues, use of technology and prudent buyouts poise Cboe Global well for growth.
Nasdaq Expands Presence in Latin America With New Agreement
by Zacks Equity Research
Nasdaq extends agreement with Nubank to provide AxiomSL regulatory reporting solution to the later and expands presence in Latin America.
Zacks Industry Outlook Intercontinental Exchange, CME Group, Nasdaq, Cboe Global and MarketAxess
by Zacks Equity Research
Intercontinental Exchange, CME Group, Nasdaq, Cboe Global and MarketAxess have been highlighted in this Industry Outlook article.
5 Securities and Exchanges Stocks to Watch Amid Market Volatility
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, NDAQ, CBOE and MKTX. However, compliance with regulations remains a challenge.
MarketAxess (MKTX) Surges 6.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
MarketAxess (MKTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.